A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis

This publication has 12 references indexed in Scilit:

• Recent Advances: Cardiology - I: Treatment of myocardial infarction, unstable angina, and angina pectoris
  BMJ, 1994
• FPL 66096: a novel, highly potent and selective antagonist at human platelet P_2T‐purinoceptors
  British Journal of Pharmacology, 1994
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
  BMJ, 1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Fibrinogen receptor antagonists - a novel class of promising antithrombotics
  Drugs of the Future, 1994
• New Antithrombotic Strategies for Resistant Thrombotic Processes
  The Journal of Clinical Pharmacology, 1994
• Low molecular weight, non-peptide fibrinogen receptor antagonists
  Journal of Medicinal Chemistry, 1992
• ADENOSINE 5′‐DIPHOSPHATE ANTAGONISTS AND HUMAN PLATELETS: NO EVIDENCE THAT AGGREGATION AND INHIBITION OF STIMULATED ADENYLATE CYCLASE ARE MEDIATED BY DIFFERENT RECEPTORS
  British Journal of Pharmacology, 1982
• SPECIFIC BUT NONCOMPETITIVE INHIBITION BY 2‐ALKYLTHIO ANALOGUES OF ADENOSINE 5′‐MONOPHOSPHATE AND ADENOSINE 5′‐TRIPHOSPHATE OF HUMAN PLATELET AGGREGATION INDUCED BY ADENOSINE 5′‐DIPHOSPHATE
  British Journal of Pharmacology, 1982